Sign in

CIK 0001752828 · <br>Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831702591
Phone
(908) 768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 8-K Event Material agreement · Other events
  2. 8-K Event Executive or director change
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 8-K Event Executive or director change
  5. 4/A Grant or award Director acquired 30,000 shares (grant or award)
  6. 4/A Grant or award Director acquired 20,385 shares (grant or award)
  7. 4/A Grant or award Director acquired 19,231 shares (grant or award)
  8. 4/A Grant or award Director acquired 28,847 shares (grant or award)
  9. 4 Grant or award Director acquired 19,231 shares (grant or award)
  10. 4 Grant or award Director acquired 28,847 shares (grant or award)
  11. 4 Grant or award Director acquired 20,385 shares (grant or award)
  12. 4 Grant or award Director acquired 30,000 shares (grant or award)
  13. 424B3 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. S-1 Offering Registration Statement
  18. 4 Grant or award Director acquired 125,000 shares (grant or award)
  19. 4 Grant or award Director acquired 125,000 shares (grant or award)
  20. 4 Grant or award Director acquired 125,000 shares (grant or award)

Page 3 of 29 · 563 filings